Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit
Related Experiment Video
Updated: Aug 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
David K Warren1, Anand Nitin, Cheri Hill
1Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Objective:
To determine the occurrence of co-colonization or co-infection with VRE and MRSA among medical patients requiring intensive care.
Design:
Prospective, single-center, observational study.
Setting:
A 19-bed medical ICU in an urban teaching hospital.
Patients:
Adult patients requiring at least 48 hours of intensive care and having at least one culture performed for microbiologic evaluation.
Results:
Eight hundred seventy-eight consecutive patients were evaluated. Of these patients, 402 (45.8%) did not have microbiologic evidence of colonization or infection with either VRE or MRSA, 355 (40.4%) were colonized or infected with VRE, 38 (4.3%) were colonized or infected with MRSA, and 83 (9.5%) had co-colonization or co-infection with VRE and MRSA. Multiple logistic regression analysis demonstrated that increasing age, hospitalization during the preceding 6 months, and admission to a long-term-care facility were independently associated with colonization or infection due to VRE and co-colonization or co-infection with VRE and MRSA. The distributions of positive culture sites for VRE (stool, 86.7%; blood, 6.5%; urine, 4.8%; soft tissue or wound, 2.0%) and for MRSA (respiratory secretions, 34.1%; blood, 32.6%; urine, 17.1%; soft tissue or wound, 16.2%) were statistically different (P < .001).
Conclusions:
Co-colonization or co-infection with VRE and MRSA is common among medical patients requiring intensive care. The recent emergence of vancomycin-resistant Staphylococcus aureus and the presence of a patient population co-colonized or co-infected with VRE and MRSA support the need for aggressive infection control measures in the ICU.
Insights
Co-colonization with vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) is frequent in intensive care units. This highlights the need for enhanced infection control measures to combat these resistant organisms.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- The prevalence of healthcare-associated infections caused by multidrug-resistant organisms, such as VRE and MRSA, remains a significant concern in intensive care units (ICUs).
- Understanding the dynamics of co-colonization and co-infection is crucial for effective infection control strategies.
Purpose of the Study:
- To investigate the occurrence of co-colonization or co-infection with vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) in adult patients admitted to a medical intensive care unit.
- To identify risk factors associated with VRE and MRSA co-colonization/co-infection.
Main Methods:
- A prospective, single-center, observational study was conducted in a 19-bed medical ICU.
- Eight hundred seventy-eight adult patients requiring at least 48 hours of intensive care and undergoing microbiologic evaluation were included.
- Data on VRE and MRSA colonization/infection and patient demographics were collected.
Main Results:
- Of 878 patients, 9.5% exhibited co-colonization or co-infection with VRE and MRSA.
- VRE colonization/infection was observed in 40.4% and MRSA in 4.3% of patients.
- Increasing age, recent hospitalization, and long-term care facility admission were associated with VRE and VRE/MRSA co-colonization/co-infection.
Conclusions:
- Co-colonization or co-infection with VRE and MRSA is a common occurrence in medical ICU patients.
- The findings underscore the necessity for stringent infection control protocols in ICUs to manage the spread of these resistant pathogens.
- The study emphasizes the importance of surveillance for both VRE and MRSA in critically ill patients.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections
Endocarditis I: Introduction